Be Ready to Handle Rxs for the New COPD Drug, Yupelri

Rx Yupelri (yoo-PEL-ree) will be a new nebulized med for COPD.

Think of Yupelri (revefenacin) as an alternative to Lonhala Magnair (glycopyrrolate). They're both long-acting "anticholinergics" given via a nebulizer...and each costs about $1,000 per month.

But there are a few differences that will give Yupelri an edge.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote